glp-1 receptor agonist long term side effects GI Adverse of Glucagon-Like Peptide-1 Agonists GLP-1 Agonists In Obesity
Description
the cohort of tirzepatide-treated patients comprised 4,887 subjects, and the control group had a size of 2,328 patients
Pappas, T
It has also given rise to concerns about counterfeit drugs that may be circulating on the market, as well as the safety and efficacy of the compounded semaglutide produced by compounding pharmacies
Diabetes Care 38:1409
Medication shortages have intermittently had an impact as well [128]
It is unclear how long treatment must continue to maintain weight loss, and whether chronic therapy is needed (as in adults)especially since drug cessation leads to rapid weight regain (35)
